grant

Optimising the therapeutic efficacy of protein-based drugs against lymph-resident diseases [ 2013 - 2016 ]

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1044802]

Researchers: Dr Lisa Kaminskas (Principal investigator) ,  Dr Jurgen Bulitta Prof Christopher Porter

Brief description Effective treatments for lymphatic diseases (such as HIV and lymph-metastatic cancers) are limited by the lack of drug assess towards the lymphatic sites of disease progression. Improving the access of drugs into lymph therefore has the significant potential to improve the treatment of these illnesses. We will therefore explore a novel approach to improving the lymphatic uptake and retention of protein-based drugs using a useful and widely used biologically compatible polymer.

Funding Amount $AUD 348,330.34

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]